- The company’s CEO discussed NTRR’s strategic acquisition of hemp retail brand Vivis and hemp cultivator J3 Holdings
- Neutra Corp. plans to finish building and lab improvements to J3 Holdings in 2019
- The company’s focus is on CBD as an option to treat types of chronic pain
- CBD sales in the U.S. are projected to exceed $20 billion by 2024
Texas-based Neutra Corp. (OTCQB: NTRR) is expanding into hemp cultivation and purified hemp extract products. Its CEO, Sydney Jim, discussed the company’s operations and objectives in an exclusive interview with NetworkNewsWire (http://cnw.fm/b07SI). Jim, a former professional tennis player, emphasized the company’s motivation to help the next generation of athletes with pain management. During the interview, he talks about dealing with pain, not only as a former professional athlete but, on an occasion as recent as last year, when he suffered multiple severe injuries and broken bones as a result of an accident.
Jim knows the benefits of hemp-based products first-hand, and CBD may offer an option for treating different types of chronic pain. A study cited by Harvard University showed that CBD applied on the skin could help lower pain and inflammation due to arthritis (http://cnw.fm/q4dD5). Other research demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain – two of the most difficult types of chronic pain to treat.
Neutra Corp.’s goal in 2019 is to become vertically involved in the hemp market, from cultivation to formulation of products and distribution for retail sales in an ever-growing market. Leading cannabis researchers BDS Analytics and Arcview Market Research project that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024, forecasting a 49 percent compound annual growth rate across all distribution channels (http://cnw.fm/ummU2).
Neutra’s interests go above and beyond profit. “Most of our focus, obviously, is in our quality and potency of our products, because there is a vast difference between very cheap products and quality products,” Jim said in the interview. It takes a lot of time to extract CBD and make sure only the best quality is made available, which is why those particular products are relatively expensive, Neutra Corp.’s CEO added.
Jim also talked about the company’s strategic acquisition of Vivis, a hemp retail brand with which the Neutra CEO has personally worked. Vivis’ extracts are certified by a third-party lab to ensure their quality. Each Vivis product comes with a certificate of analysis as proof of quality, Jim explained.
Neutra Corp. also aims to finish the building and lab improvements of hemp cultivator J3 Holdings, for which the company recently submitted a letter of intent. J3 Holdings owns a lot of land where hemp can be cultivated, as well as a warehouse – assets that are expected to increase Neutra Corp.’s value. In September, Neutra Corp. plans to “finalize the equipment going in there (J3 Holdings) and wrap the financing up to hit the ground running in 2020.”
On a final note, the company’s CEO expressed his hope of bringing Vivis and J3 together to strengthen Neutra’s market infiltration while helping it become a vertically integrated company with both a strong market presence and an established brand that’s known for the superiority of its product and its commitment to quality.
For more information, visit the company’s website at www.NeutraInc.com
NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
